» Articles » PMID: 30560340

Gut Microbiome, Short-Chain Fatty Acids, and Mucosa Injury in Young Adults with Human Immunodeficiency Virus Infection

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2018 Dec 19
PMID 30560340
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: HIV progression is characterized by immune activation and microbial translocation from the gut. Short-chain fatty acids (SCFAs) are essential for gut homeostasis. Decreased intestinal SCFAs play a role in rapid HIV progression.

Aims: To compare the SCFA profile, intestinal microbiome, and intestinal mucosal injury between patients with HIV (but not AIDS) and healthy controls.

Methods: This was a prospective study of 15 patients without AIDS and 10 controls conducted between July 2016 and January 2017 at the Institute of Dermatology and Venereology (Sichuan Academy of Medical Sciences). Stool specimens were collected to analyze the microbiome and SCFAs. Blood I-FABP and D-lactate (gut injury markers) were measured as well as T cells in HIV-positive patients. Intestinal mucosa was observed by colonoscopy.

Results: Rikenellaceae, Microbacteriaceae, Roseburia, Lachnospiraceae, Alistipes, and Ruminococcaceae were decreased, while Moraxellaceae and Psychrobacter were increased in HIV-positive patients. Butyric acid (p = 0.04) and valeric acid (p = 0.03) were reduced in HIV-positive patients. Colonoscopy revealed no visible damage in all subjects. There were no differences in I-FABP and D-lactate between groups. Butyric and valeric acids mainly positively correlated with Rikenellaceae, Ruminococcaceae, Alistipes, Roseburia, and Lachnospiraceae. CD8+ cells were positively correlated with Proteobacteria. CD4+ cells, and CD4/CD8 were negatively correlated with acetic acid. CD8+ cells were positively correlated with valeric acid.

Conclusion: The differences in the distribution of intestinal flora between HIV-infected and healthy individuals, especially some SCFAs, suggest that there is already a predisposition to intestinal mucosa damage in HIV-infected individuals.

Citing Articles

Alterations of the Intestinal Mucosal Barrier and Gut Fungal Microbiome in Asymptomatic HIV-Infected Patients.

Li W, Qing Y, Yu Q, Zhang H, Rang Z, Li S Can J Infect Dis Med Microbiol. 2025; 2024:6995192.

PMID: 39886072 PMC: 11779998. DOI: 10.1155/cjid/6995192.


Changes in Type 1 Diabetes-Associated Gut Microbiota Aggravate Brain Ischemia Injury by Affecting Microglial Polarization Via the Butyrate-MyD88 Pathway in Mice.

Zeng X, Ma C, Fu W, Xu Y, Wang R, Liu D Mol Neurobiol. 2024; 62(3):3764-3780.

PMID: 39322832 DOI: 10.1007/s12035-024-04514-9.


Intestinal and hepatic benefits of BBR-EVO on DSS-induced experimental colitis in mice.

Wang W, Han Y, Yin W, Wang Q, Wu Y, Du M Front Microbiol. 2024; 15:1428327.

PMID: 39296302 PMC: 11408294. DOI: 10.3389/fmicb.2024.1428327.


HIV-associated neurocognitive disorder: key implications of the microbiota-gut-brain axis.

Hu A, Zaongo S, Harypursat V, Wang X, Ouyang J, Chen Y Front Microbiol. 2024; 15:1428239.

PMID: 39155987 PMC: 11327151. DOI: 10.3389/fmicb.2024.1428239.


Dietary copper improves intestinal structural integrity in juvenile grass carp () probably related to its increased intestinal antioxidant capacity and apical junction complex.

Ma R, Feng L, Wu P, Liu Y, Ren H, Jin X Anim Nutr. 2024; 18:96-106.

PMID: 39056059 PMC: 11269860. DOI: 10.1016/j.aninu.2024.02.005.


References
1.
Feinberg J . In the clinic. Management of newly diagnosed HIV infection. Ann Intern Med. 2011; 155(7):ITC41. DOI: 10.7326/0003-4819-155-7-201110040-01004. View

2.
Cohen M, Shaw G, McMichael A, Haynes B . Acute HIV-1 Infection. N Engl J Med. 2011; 364(20):1943-54. PMC: 3771113. DOI: 10.1056/NEJMra1011874. View

3.
Wilcox C, Saag M . Gastrointestinal complications of HIV infection: changing priorities in the HAART era. Gut. 2008; 57(6):861-70. DOI: 10.1136/gut.2006.103432. View

4.
Li S, Armstrong A, Neff C, Shaffer M, Lozupone C, Palmer B . Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy. Clin Pharmacol Ther. 2016; 99(6):600-11. PMC: 4927263. DOI: 10.1002/cpt.363. View

5.
Chevalier M, Petitjean G, Dunyach-Remy C, Didier C, Girard P, Manea M . The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation. PLoS Pathog. 2013; 9(6):e1003453. PMC: 3688532. DOI: 10.1371/journal.ppat.1003453. View